These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9691927)
1. Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy. Avallone R; Zeneroli ML; Venturini I; Corsi L; Schreier P; Kleinschnitz M; Ferrarese C; Farina F; Baraldi C; Pecora N; Frigo M; Baraldi M Gut; 1998 Jun; 42(6):861-7. PubMed ID: 9691927 [TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failure. Zeneroli ML; Venturini I; Corsi L; Avallone R; Farina F; Ardizzone G; Centanaro M; Arrigo A; Schreier P; Kleinschnitz M; Baraldi M Scand J Gastroenterol; 1998 Mar; 33(3):310-3. PubMed ID: 9548626 [TBL] [Abstract][Full Text] [Related]
3. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Basile AS; Harrison PM; Hughes RD; Gu ZQ; Pannell L; McKinney A; Jones EA; Williams R Hepatology; 1994 Jan; 19(1):112-21. PubMed ID: 8276347 [TBL] [Abstract][Full Text] [Related]
4. Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake. Perney P; Butterworth RF; Mousseau DD; Lavoie J; Fabbro-Peray P; Blanc F; Layrargues GP Metab Brain Dis; 1998 Sep; 13(3):201-10. PubMed ID: 9804365 [TBL] [Abstract][Full Text] [Related]
5. Hepatic encephalopathy in liver transplant recipients precipitated by benzodiazepines present in transfused blood. Zeneroli ML; Venturini I; Avallone R; Farina F; Corsi L; Baraldi C; Ardizzone G; Centanaro M; Arrigo A; Baraldi M Transplantation; 1996 Sep; 62(6):764-7. PubMed ID: 8824474 [TBL] [Abstract][Full Text] [Related]
6. "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Mullen KD; Szauter KM; Kaminsky-Russ K Lancet; 1990 Jul; 336(8707):81-3. PubMed ID: 1975325 [TBL] [Abstract][Full Text] [Related]
7. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. Olasmaa M; Rothstein JD; Guidotti A; Weber RJ; Paul SM; Spector S; Zeneroli ML; Baraldi M; Costa E J Neurochem; 1990 Dec; 55(6):2015-23. PubMed ID: 2172467 [TBL] [Abstract][Full Text] [Related]
8. Ammonia and endogenous benzodiazepine-like compounds in the pathogenesis of hepatic encephalopathy. Venturini I; Corsi L; Avallone R; Farina F; Bedogni G; Baraldi C; Baraldi M; Zeneroli ML Scand J Gastroenterol; 2001 Apr; 36(4):423-5. PubMed ID: 11336169 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study. Venturini I; Ferrieri A; Farina F; Cosenza F; Avallone R; Corsi L; Baraldi M; Zeneroli ML Drugs Exp Clin Res; 2005; 31(4):161-8. PubMed ID: 16223206 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Venturini I; Zeneroli ML; Corsi L; Avallone R; Farina F; Alho H; Baraldi C; Ferrarese C; Pecora N; Frigo M; Ardizzone G; Arrigo A; Pellicci R; Baraldi M Life Sci; 1998; 63(14):1269-80. PubMed ID: 9771915 [TBL] [Abstract][Full Text] [Related]
11. Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy. Baraldi M; Avallone R; Corsi L; Venturini I; Baraldi C; Zeneroli ML Metab Brain Dis; 2009 Mar; 24(1):81-93. PubMed ID: 19082698 [TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of endogenous benzodiazepine-receptor ligands in patients with hepatic encephalopathy: a comparative study. Hernández-Avila CA; Shoemaker WJ; Ortega-Soto HA J Psychiatry Neurosci; 1998 Sep; 23(4):217-22. PubMed ID: 9785700 [TBL] [Abstract][Full Text] [Related]
14. Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Basile AS; Pannell L; Jaouni T; Gammal SH; Fales HM; Jones EA; Skolnick P Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5263-7. PubMed ID: 1973539 [TBL] [Abstract][Full Text] [Related]
15. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy. Rothstein JD; Olasmaa M Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124 [TBL] [Abstract][Full Text] [Related]
17. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. Basile AS; Hughes RD; Harrison PM; Murata Y; Pannell L; Jones EA; Williams R; Skolnick P N Engl J Med; 1991 Aug; 325(7):473-8. PubMed ID: 1649403 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis. Zeneroli ML; Venturini I; Stefanelli S; Farina F; Miglioli RC; Minelli E; Amedei ER; Ferrieri A; Avallone R; Baraldi M Pharmacol Res; 1997 Jun; 35(6):557-60. PubMed ID: 9356209 [TBL] [Abstract][Full Text] [Related]
19. The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand. Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P Adv Biochem Psychopharmacol; 1990; 46():189-200. PubMed ID: 1963266 [TBL] [Abstract][Full Text] [Related]
20. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat. Widler P; Fisch HU; Schoch P; Zimmermann A; Schläpfer TE; Reichen J Hepatology; 1993 Dec; 18(6):1459-64. PubMed ID: 8080486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]